These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [HLA compatibility and antigenic re-exposure. Impact on the clinical course of cadaver kidney transplantation]. Fernández Aparicio T; Miñana López B; Polo Villar G; Diaz González R; Fraile Gómez B; Aguirre Benites F; Morales Cerdán JM; Leiva Galvis O Arch Esp Urol; 2000; 53(1):53-64. PubMed ID: 10730425 [TBL] [Abstract][Full Text] [Related]
23. Negative effect of HLA-DQ antigen compatibility (concordance) on the survival of kidney grafts. Fukuda Y; Hoshino S; Kimura A; Dohi K; Sasazuki T Transplant Proc; 1994 Aug; 26(4):1887-90. PubMed ID: 8066613 [No Abstract] [Full Text] [Related]
24. DNA heteroduplex analysis reveals mismatching of DR alleles in HLA-DR serologically matched cadaveric renal transplantation. Connolly J; Sinnott PJ; Ivinson AJ; Parrott NR; Martin S; Dyer PA Transplant Proc; 1993 Dec; 25(6):3064. PubMed ID: 7903497 [No Abstract] [Full Text] [Related]
25. Is it time to prospectively match human leukocyte antigen proteins for lung transplantation? Neuringer IP; Aris RM Transplantation; 2010 Oct; 90(8):823-4. PubMed ID: 20697323 [No Abstract] [Full Text] [Related]
26. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711 [TBL] [Abstract][Full Text] [Related]
27. Strong impact of HLA-DR-matching on graft survival in 413 consecutive cadaver kidney transplants performed in Copenhagen over an eight-year period. Jakobsen BK; Ryder LP; Ladefoged J; Løkkegaard H; Nielsen B; Olgaard K; Svejgaard A Transplant Proc; 1995 Dec; 27(6):3452-3. PubMed ID: 8540048 [No Abstract] [Full Text] [Related]
28. Preliminary analysis of HLA matching in pancreas and liver transplantation. Collaborative Transplant Study. Opelz G Transplant Proc; 1993 Aug; 25(4):2652-3. PubMed ID: 8356708 [No Abstract] [Full Text] [Related]
29. Survival of serologically HLA typed and matched cadaveric kidney transplants and patients: influence of serologic retyping of donors. Thorogood J; Doxiadis II; Schreuder GM; Persijn GG; van Rood JJ Transplant Proc; 1993 Dec; 25(6):3051-2. PubMed ID: 8266449 [No Abstract] [Full Text] [Related]
30. Current status of organ transplantation in Taiwan. Lee CJ Transplant Proc; 1996 Jun; 28(3):1196-8. PubMed ID: 8658624 [No Abstract] [Full Text] [Related]
31. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation. Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307 [TBL] [Abstract][Full Text] [Related]
32. Effect of HLA matching on graft survival in live donor kidney transplantations. Velidedeoğlu E; Bilgin N; Haberal M Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491 [No Abstract] [Full Text] [Related]
33. Impact of allocating cadaveric kidneys solely to "centers of excellence" versus by HLA matching. Gjertson DW; Takemoto S; Cecka JM; Terasaki PI Transplant Proc; 1995 Feb; 27(1):653-5. PubMed ID: 7879132 [No Abstract] [Full Text] [Related]
34. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Opelz G; Döhler B Transplantation; 2007 Jul; 84(2):137-43. PubMed ID: 17667803 [TBL] [Abstract][Full Text] [Related]
35. Long-term success rate of HLA-DRB1 compatible kidney transplants. Nojima M; Ichikawa Y; Ihara H; Ishibashi M; Ohshima S; Ikoma F Transplant Proc; 1993 Dec; 25(6):3056-9. PubMed ID: 8266451 [No Abstract] [Full Text] [Related]
36. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility. Doxiadis II; de Fijter JW; Mallat MJ; Haasnoot GW; Ringers J; Persijn GG; Claas FH Transplantation; 2007 May; 83(9):1207-13. PubMed ID: 17496537 [TBL] [Abstract][Full Text] [Related]
37. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility. Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092 [TBL] [Abstract][Full Text] [Related]
38. Kidney transplantation in Cyprus. Kyriakides GK; Hadjigavriel M; Nicolaou P; Nicolaides A; Kyriakides M Transplant Proc; 1993 Apr; 25(2):2129-30. PubMed ID: 8470291 [No Abstract] [Full Text] [Related]
39. Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications. Doxiadis II; Smits JM; Stobbe I; Schreuder GM; Persijn GG; van Houwelingen H; van Rood JJ; Claas FH Transplant Proc; 1996 Feb; 28(1):224. PubMed ID: 8644189 [No Abstract] [Full Text] [Related]
40. Changing the priority for HLA matching in kidney transplantation. Kamoun M; Sellers MT N Engl J Med; 2004 May; 350(20):2095-6; author reply 2095-6. PubMed ID: 15146574 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]